Eli Lilly said on Wednesday the U.S. health regulator has approved its drug to treat adults with moderate-to-severe Crohn's ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other healthcare stocks Jim Cramer has made bold predictions about. Healthcare has been ...

In order to find the best storage ideas to save you time and space after the holidays, we reached out to several professional organizers for their expert recommendations. Keep reading to find the ...

To QB or not to QB? That was the question Eli Stowers asked himself as the 2023 college football season approached for New Mexico State. The question answered itself. The answer not to QB.

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved and that specialty pharmacies and online companies need to stop ...

In contrast to all that, many investors prefer to focus on companies like Eli Lilly (NYSE:LLY), which has not only revenues, but also profits. While profit isn't the sole metric that should be ...

In its memo announcing the waiver, the NCAA also announced that it has filed a notice of appeal to the ruling in Pavia's case. Pavia sued the NCAA in November over its eligibility standards ...

Shelby Knowles / Bloomberg via Getty Images Shares of ResMed and Inspire Medical Systems fell after the FDA approved Eli Lilly's weight-loss drug Zepbound to treat moderate-to-severe obstructive ...